The facility, focused on finding treatments for mental health disorders, will be the first of its kind in the US.
Last Wednesday (September 4), Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research, which will focus on using psychedelic compounds such as LSD, ketamine, and psilocybin to treat mental health problems. The center, founded with $17 million in donations, is the first of its kind in the US, according to The New York Times. It follows the opening of Imperial College London’s psychedelic treatment center in April 2019.
The Post is Johns Hopkins Launches Research Center on Psychedelics appeared first on The Scientist